Study on the Relationship between AMPK/UCP2 Pathway and Mitochondrial Dysfunction in Granulosa Cells of Polycystic Ovay Syndrome

Abstract
Figure/Table
References
Related Citation (1)

Download: PDF (5219 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the changes of the AMP-activated protein kinase (AMPK)/uncoupling protein 2 (UCP2)(AMPK/UCP2) pathway in ovarian granulosa cells with PCOS and its relationship with mitochondrial dysfunction. Methods: PCOS mouse models and normally fed mice, ovarian granulosa cells from the two mice were extracted, and the protein expression levels of AMPKα, p-AMPKα and UCP2 were detected by western blotting. The ROS and ATP content of granulosa cells were determined by colorimetric and chemiluminescence immunoassays to assess mitochondrial function. Pearson correlation analysis was used to determine the correlation between AMPK/UCP2 pathway-related proteins, ROS and ATP. Results: P-AMPKα/GAPDH(0.12±0.09), AMPKα/GAPDH(0.35±0.40), P-AMPKα/AMPKα(0.56±0.33) and ATP(0.36±0.04) pmol/mg in PCOS model mice were lower than those in non-POCS groups, while UCP2/GAPDH(1.18±0.28) and ROS(48810.92±4498.08) were lower than those in non-POCS groups. The fluorescence intensity of DCF was higher than that of the non-POCS group(P<0.05). AMPK was positively correlated with ATP and negatively correlated with ROS. UCP2 was positively correlated with ROS and negatively correlated with ATP. Conclusion: There are abnormal changes such as decreased AMPK expression and increased UCP2 expression in ovarian granulosa cells of PCOS, and AMPK is positively and negatively correlated with mitochondrial function indexes ATP and ROS, while UCP2 is the opposite, suggesting that the imbalance in the expression and activity of AMPK/UCP2 pathway in PCOS may be one of the molecular mechanisms leading to mitochondrial dysfunction. Regulation of AMPK/UCP2 pathway activity may be a potential therapeutic target to ameliorate PCOS-related mitochondrial dysfunction.

Key words： polycystic ovary syndrome AMP-activated protein kinase(AMPK) uncoupling protein 2(UCP2) mitochondrial dysfunction granule cells

Received: 15 November 2023

PACS:

R285.5

Corresponding Authors: ZHANG Ju-shun. E-mail: 535294850@qq.com

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Ju-shun
	HE Bin-bin
	WEN Shi-di

Cite this article:

ZHANG Ju-shun,HE Bin-bin,WEN Shi-di. Study on the Relationship between AMPK/UCP2 Pathway and Mitochondrial Dysfunction in Granulosa Cells of Polycystic Ovay Syndrome[J]. Chinese Journal of Biomedical Engineering, 2024, 33(1): 1-8.

URL:

http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/ OR http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/Y2024/V33/I1/1

[1] Cong J, Li M, Wang Y, et al.Protective effects of electroacupuncture on polycystic ovary syndrome in rats: Down-regulating Alas2 to inhibit apoptosis, oxidative stress, and mitochondrial dysfunction in ovarian granulosa cells[J]. Tissue Cell, 2023,82:102090.
[2] Prabhu NB, Adiga D, Kabekkodu SP, et al.Bisphenol A exposure modulates reproductive and endocrine system, mitochondrial function and cellular senescence in female adult rats: A hallmarks of polycystic ovarian syndrome phenotype[J]. Environ Toxicol Pharmacol, 2022,96:104010.
[3] Chappell NR, Zhou B, Hosseinzadeh P, et al.Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome[J]. F S Sci, 2021,2(1):101-112.
[4] Ma N, Zhou J, Zhou Z, et al.Effects of UBE3A on the insulin resistance in polycystic ovary syndrome through the ubiquitination of AMPK[J]. BMC Endocr Disord, 2023,23(1):152.
[5] Alshafei M, Schulze T, Morsi M, et al.Short-term inhibition of translation by cycloheximide concurrently affects mitochondrial function and insulin secretion in islets from female mice[J]. Int J Mol Sci, 2023,24(20):15464.
[6] Liu Y, Jiang H, Xing FQ, et al.Uncoupling protein 2 expression affects androgen synthesis in polycystic ovary syndrome[J]. Endocrine, 2013,43(3):714-723.
[7] Yin L, Qi S, Zhu Z.Advances in mitochondria-centered mechanism behind the roles of androgens and androgen receptor in the regulation of glucose and lipid metabolism[J]. Front Endocrinol (Lausanne), 2023,14:1267170.
[8] Obstetrics and Gynecology Branch of Chinese Medical Association. Chinese guidelines of polycystic ovary syndrome[J]. Chin J Obstet Gynecol, 2018, 53(1): 2-6.
(中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志,2018,53(1):2-6.)
[9] Shukla P, Melkani GC.Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS[J]. Rev Endocr Metab Disord, 2023,24(2):317-326.
[10] Froment P, Plotton I, Giulivi C, et al.At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism[J]. Hum Reprod, 2022,37(6):1207-1228.
[11] Yin L, Luo M, Wang R, et al.Mitochondria in sex hormone-induced disorder of energy metabolism in males and females[J]. Front Endocrinol (Lausanne), 2021,12:749451.
[12] Mu F, Zhao J, Zhao M, et al. Styrax (Liquidambar orientalis Mill.) promotes mitochondrial function and reduces cardiac damage following myocardial ischemic injury: the role of the AMPK-PGC1α signaling pathway[J]. J Pharm Pharmacol, 2023,10(28):rgad093.
[13] Mi &ċi &ċ B, Djordjevic A, Veli &čkovi &ċ N,et al. AMPK activation as a protective mechanism to restrain oxidative stress in the insulin-resistant state in skeletal muscle of rat model of PCOS subjected to postnatal overfeeding[J]. Biomedicines, 2023,11(6):1586.
[14] Zeber-Lubecka N, Ciebiera M, Hennig EE. polycystic ovary syndrome and oxidative stress-from bench to bedside[J]. Int J Mol Sci, 2023,24(18):14126.